Purdue Pharma Bankruptcy Plan Conditionally Approved With $4.3B Sackler Share
WHITE PLAINS, N.Y. — A New York federal bankruptcy judge on Sept. 1 approved an amended reorganization plan for OxyContin maker Purdue Pharma LP that includes $4.3 billion in contributions from...To view the full article, register now.
Already a subscriber? Click here to view full article